Clinical Trials

Navigators have 2 key roles related to the important work of improving diversity in clinical trials.

“What’s in It for Me?” Helping Patients Understand Oncology Clinical Trials

July 2023 Vol 14, No 7

Cancer clinical trials offer patients an opportunity to be treated with the most cutting-edge and promising cancer therapies available, but the majority of patients who are offered these trials still are not signing up for them. This might frustrate those in the know, but many patients simply do not understand what these trials entail.

Myths and Truths About Clinical Trials

June 2023 Vol 14, No 6

Executive Summary: Clinical trials for cancer treatments offer patients invaluable access to emerging therapies but are not always well understood by patients or even the medical community. Closing the gap between high patient interest levels and low patient enrollment will help thousands of patients benefit from cutting-edge therapies while accelerating advances for future patients.

Multiple Myeloma: Overview, Treatments, and the Navigator’s Role in Clinical Trials

Chelsea Passwater, DNP, APRN, AGCNS-BC, OCN, Denise Brigham, RN, MPH, OCN, CCRC, Shana Smith, MSN, RN, OCN

March 2022 Vol 13, No 3

Sacituzumab Govitecan Moves to Second-Line Therapy for Metastatic Triple-Negative Breast Cancer: Applying the Lessons from Clinical Trials to Clinical Practice

February 2022 Clinical Trials to Clinical Practice

Each year, approximately 250,000 cases of breast cancer are diagnosed in the United States.

The Role of Navigators, Patients, and Community Members in Accruing for Clinical Trials

May 2021 Vol 12, No 5

You can bring a community together to improve the impact of clinical trials – here’s how.

Emerging Combination Therapies in Renal-Cell Carcinoma: Applying the Lessons from Clinical Trials to Clinical Practice

March 2021 Clinical Trials to Clinical Practice

Cancer Clinical Trials: The Navigator’s Role in Ensuring Inclusivity

AONN+ 2020 Conference Highlights Special Feature

Underrepresented in cancer clinical trials, racial and ethnic minorities often miss out on the benefits of research participation. Educating potential participants on clinical trials can increase enrollment among populations that have been commonly overlooked.

Becoming an “AYA Champion” to Increase AYA Enrollment on Clinical Trials

September 2019 Vol 10, No 9

Adolescent and young adult (AYA) patients aged 15 to 39 years are significantly underrepresented in cancer clinical trials.

Navigation’s Impact on Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies

Claire White, BSN, RN, CPHON, Laura Hynes, MA, BSN, RN, Lucy J. Gansauer, MSN, RN, OCN, CCRP, Mary Van Cleave, BSN, RN, OCN, Lavinia Dobrea, RN, MS, OCN, Amy Meleason, BSN, RN, OCN, Daniel McGough, BS, CCRP

August 2019 Vol 10, No 8

What you need to know about discussing clinical trials with your patients.

Loading More Articles